SARAH MURPHY: Open Payments
NPI 1578716213 · STANTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 41 payments from 17 companies in 2025. Trend: 2023 $765 · 2024 $785 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $149 |
| Lilly USA, LLC | 11 | $148 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 2 | $54 |
| SANOFI-AVENTIS U.S. LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, GIVLAARI, TZIELD, JARDIANCE, Wegovy, UBRELVY.
Industry payments across KY — which companies pay providers there.
